Carl Genberg
Chief Tech/Sci/R&D Officer at Ceragenix Corp.
Carl Genberg active positions
Companies | Position | Start | End |
---|---|---|---|
Ceragenix Corp. | Chief Tech/Sci/R&D Officer | 2002-01-31 | - |
Career history of Carl Genberg
Former positions of Carl Genberg
Companies | Position | Start | End |
---|---|---|---|
N8 Medical, Inc.
N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Chief Executive Officer | - | 2019-05-31 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Chief Tech/Sci/R&D Officer | 2005-04-30 | 2010-03-28 |
OnSource Corp. | Corporate Officer/Principal | - | 2005-06-26 |
Training of Carl Genberg
Cornell University | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
Ceragenix Corp. | |
N8 Medical, Inc.
N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Carl Genberg
- Experience